Market research
S0Z.F Sientra, Inc
F EUR Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 2M
- P/E ratio
- Not available
- Analyst target
- 11.29
- Dividend yield
- 0.0%
- Beta
- 1.59
Profile
Company facts
- Exchange
- F
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Medical Devices
- ISIN
- US82621J1051
- Market cap
- 2M
- P/E ratio
- Not available
- Analyst target
- 11.29
- Dividend yield
- 0.0%
- Beta
- 1.59
About
About Sientra, Inc
Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products in the United States and internationally. It offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra Round, Sientra Teardrop, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names. The company also provides body contouring products; facial and nasal implants; saline filled sizers. It serves to hospitals, surgery centers, plastic surgeons, dermatologists and other specialties. The company was formerly known as Juliet Medical, Inc. and changed its name to Sientra, Inc. in April 2007. Sientra, Inc. was incorporated in 2003 and is headquartered in Santa Barbara, California.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the S0Z.F discussion.
5 years, 5 months ago
Sientra, Inc is currently in a long term uptrend where the price is trading 33.1% above its 200 day moving average.
From a valuation standpoint, the stock is 99.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 5.1.
Sientra, Inc's total revenue sank by 2.4% to $23M since the same quarter in the previous year.
Its net income has dropped by 4.9% to $-21M since the same quarter in the previous year.
Finally, its free cash flow grew by 42.9% to $-8M since the same quarter in the previous year.
Based on the above factors, Sientra, Inc gets an overall score of 3/5.